FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to transfusiology, and can be used to determine the coagulation potential of lyophilised plasma. After liquid plasma is restored in vitro, a thrombodynamic test is conducted. Method includes determining test parameters, specifically: delay time of onset of clot formation, average rate of clot growth, fibrin clot size, clot density and the time of onset of spontaneous clots, if within the reference values, an undisturbed coagulation potential of the lyophilized plasma is determined.
EFFECT: method enables informative determination of coagulation potential of lyophilised plasma in vitro due to the determination after recovery of the liquid state of the plasma in vitro of thrombodynamic test values: delay time of the onset of clot formation, average clot growth rate, fibrin clot size, clot density and spontaneous clot onset time, which can be used in transfusiology departments and blood banks.
1 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN SEVERE BURN INJURY | 2020 |
|
RU2737277C1 |
METHOD FOR EVALUATING PLASMA HAEMOSTASIS | 2023 |
|
RU2816538C1 |
SCREENING-TEST OF DETERMINING COAGULATION CONTACT WAY (STOKPK) | 2017 |
|
RU2660706C1 |
METHOD FOR PREDICTION OF THE BURN DISEASE OUTCOME IN THE PATIENTS WITH SEVERE THERMAL TRAUMA | 2020 |
|
RU2738303C1 |
METHOD FOR DETERMINING ANTICOAGULANT POTENTIAL OF BLOOD PLASMA FOR DIAGNOSING PRETHROMBOTIC CONDITIONS | 2024 |
|
RU2835822C1 |
USE OF PINANYLSULFIDE WITH METHYL MERCAPTOACETATE FRAGMENT - METHYL 2-({[(1S,2R,5S)-6,6-DIMETHYLBICYCLO[3.1.1]HEPT-2-YL]METHYL}THIO) ACETATE, AS AN AGENT WITH INHIBITORY EFFECT ON PLATELET ACTIVATION | 2015 |
|
RU2671567C2 |
METHOD FOR PREDICTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH POLYTRAUMA | 2018 |
|
RU2699050C1 |
METHOD FOR PREDICTION OF PANCREATIC NECROSIS ACCOMPANYING ACUTE PANCREATITIS | 2024 |
|
RU2840954C1 |
METHOD FOR DETERMINING CONCENTRATION OF UNFRACTIONATED HEPARIN IN HUMAN PLASMA | 2024 |
|
RU2830354C1 |
METHOD FOR CORRECTION OF HAEMOSTASIS DISORDERS IN FEMALES ACCOMPANYING EXTRACORPOREAL FERTILIZATION | 2018 |
|
RU2723358C2 |
Authors
Dates
2025-05-19—Published
2024-06-21—Filed